Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von University of Texas MD Anderson Cancer Center (14)
2023
-
Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide
The Lancet Oncology, Vol. 24, Núm. 12, pp. e472-e518
2021
-
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox
The Lancet Oncology, Vol. 22, Núm. 1, pp. e18-e28
-
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
npj Breast Cancer, Vol. 7, Núm. 1
-
The ESSO core curriculum committee update on surgical oncology
European Journal of Surgical Oncology, Vol. 47, Núm. 11, pp. e1-e30
2020
-
Oncoplastic Breast Surgery Techniques for the General Surgeon
Springer International Publishing, pp. 1-635
-
Preface
Oncoplastic Breast Surgery Techniques for the General Surgeon
-
Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study)
Breast Cancer Research and Treatment, Vol. 184, Núm. 2, pp. 469-479
2019
-
European Society of Surgical Oncology's strategy for clinical research: Paving the way for a culture of research in cancer surgery
European Journal of Surgical Oncology, Vol. 45, Núm. 9, pp. 1515-1519
2018
-
Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Annals of Oncology, Vol. 29, Núm. 2, pp. 405-417
-
Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis
Cancer, Vol. 124, Núm. 14, pp. 2923-2930
2016
-
70-Gene signature as an aid to treatment decisions in early-stage breast cancer
New England Journal of Medicine, Vol. 375, Núm. 8, pp. 717-729
2010
-
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer
Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465
2000
-
Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer
Annals of Surgical Oncology, Vol. 7, Núm. 8, pp. 581-587
-
Role of specimen radiography in patients treated with skin-sparing mastectomy for ductal carcinoma in situ of the breast
Annals of Surgical Oncology, Vol. 7, Núm. 7, pp. 544-548